$APTV

Delphi Automotive PLC

CIK:0001521332|SEC Filings

Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 3,274	$ 3,199	$ 6,306	$ 6,186
Operating expenses:
Cost of sales	2,499	2,468	4,861	4,784
Selling, general and administrative	332	327	660	636
Amortization	52	52	104	103
Restructuring (Note 7)	24	27	40	49
Total operating expenses	2,907	2,874	5,665	5,572
Operating income	367	325	641	614
Interest expense	(62)	(92)	(146)	(185)
Other income, net	58	15	55	19
Net gain on equity method transactions	3	46	3	46
Income before income taxes and equity loss	366	294	553	494
Income tax (expense) benefit	(52)	(16)	(94)	(342)
Income before equity loss	314	278	459	152
Equity loss, net of tax	(17)	(14)	(34)	(29)
Income from continuing operations	297	264	425	123
(Loss) income from discontinued operations, net of tax (Note 21)	(50)	133	13	263
(Loss) income from discontinued operations, net of tax (Note 21)	(50)	128	10	257
Net income	247	397	438	386
Net income attributable to noncontrolling interest	0	5	3	6
Net loss attributable to redeemable noncontrolling interest	(1)	(1)	(2)	(2)
Net income attributable to Aptiv	248	393	437	382
Income from continuing operations	298	265	427	125
(Loss) income from discontinued operations	$ (50)	$ 128	$ 10	$ 257
Basic net income (loss) per share:
Continuing operations (in usd per share)	$ 1.41	$ 1.21	$ 2.02	$ 0.56
Discontinued operations (in usd per share)	(0.24)	0.59	0.04	1.15
Basic net income per share attributable to Aptiv (in usd per share)	$ 1.17	$ 1.80	$ 2.06	$ 1.71
Weighted average number of basic shares outstanding	211,560	217,730	211,840	223,910
Diluted net income per share (Note 12):
Continuing operations (in usd per share)	$ 1.40	$ 1.21	$ 2.01	$ 0.55
Discontinued operations (in usd per share)	(0.23)	0.59	0.05	1.15
Diluted net income per share attributable to Aptiv (in usd per share)	$ 1.17	$ 1.80	$ 2.06	$ 1.70
Weighted average number of diluted shares outstanding	212,100	218,110	212,530	224,320

Consolidated Statements Of Cash Flows - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities:
Net income	$ 247	$ 397	$ 438	$ 386
(Loss) income from discontinued operations, net of tax (Note 21)	(50)	133	13	263
Income from continuing operations	297	264	425	123
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation			280	276
Amortization	52	52	104	103
Amortization of deferred debt issuance costs			4	5
Restructuring expense, net of cash paid			(14)	(9)
Deferred income taxes			(32)	309
Pension and other postretirement benefit expenses			10	11
Loss from equity method investments, net of dividends received			34	29
Loss on extinguishment of debt	(44)	0	(39)	3
Loss on sale of assets		(5)	1	(6)
Share-based compensation			50	64
Net gain on equity method transactions	(3)	(46)	(3)	(46)	$ (33)
Changes in operating assets and liabilities:
Accounts receivable, net			(314)	(204)
Inventories			(230)	(108)
Other assets			(204)	(93)
Accounts payable			144	163
Accrued and other long-term liabilities			(136)	(106)
Other, net			9	19
Pension contributions			(7)	(2)
Net cash provided by operating activities from continuing operations			82	531
Net cash (used in) provided by operating activities from discontinued operations			(133)	252
Net cash provided by operating activities			(51)	783
Cash flows from investing activities:
Capital expenditures			(278)	(267)
Proceeds from sale of property			2	2
Proceeds from business divestitures, net of cash sold			0	4
Proceeds from sale of technology investments			0	1
Proceeds from the sale of equity method investment			0	164
Cost of technology investments			0	(42)
Acquisition of redeemable noncontrolling interest			(67)	0
Settlement of derivatives			(3)	5
Net cash used in investing activities from continuing operations			(346)	(133)
Net cash used in investing activities from discontinued operations			(66)	(79)
Net cash used in investing activities			(412)	(212)
Cash flows from financing activities:
Net proceeds (repayments) under other short-term debt agreements			(5)	(324)
Repayment of term loans			0	(250)
Repayment of senior notes			(2,054)	0
Fees related to modification of debt agreements			0	5
Dividend received from spin-off of Versigent			1,920	0
Cash transferred to Versigent related to spin-off			(282)	0
Repurchase of ordinary shares			(322)	0
Taxes withheld and paid on employees' restricted share awards			(32)	(17)
Net cash used in financing activities from continuing operations			(775)	(596)
Net cash provided by (used in) financing activities from discontinued operations			150	(136)
Net cash used in by financing activities			(625)	(732)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash			(1)	36
(Decrease) increase in cash, cash equivalents and restricted cash			(1,089)	(125)
Cash, cash equivalents and restricted cash at beginning of period			1,854	1,574	1,574
Cash, cash equivalents and restricted cash at end of period	765	1,449	765	1,449	$ 1,854
Cash, cash equivalents and restricted cash of discontinued operations	0	328	0	328
Cash, cash equivalents and restricted cash of continuing operations	$ 765	$ 1,121	765	1,121
Supplemental non-cash investing activities:
Capital expenditures included in accounts payable			$ 116	$ 122

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 761	$ 1,575
Restricted cash	4	3
Accounts receivable, net of allowance for doubtful accounts of $29 million and $28 million, respectively (Note 2)	2,434	1,910
Inventories (Note 3)	2,038	1,789
Other current assets (Note 4)	766	627
Current assets of discontinued operations (Note 21)	0	2,841
Total current assets	6,003	8,745
Long-term assets:
Property, net	2,756	2,872
Operating lease, right-of-use assets	305	331
Investments in affiliates (Note 21)	1,255	1,288
Intangible assets, net (Note 2)	1,875	1,997
Goodwill (Note 2)	3,937	4,008
Other long-term assets (Note 4)	1,865	1,816
Long-term assets of discontinued operations (Note 21)	0	2,356
Total long-term assets	11,993	14,668
Total assets	17,996	23,413
Current liabilities:
Short-term debt (Note 8)	23	23
Accounts payable	1,910	1,623
Accrued liabilities (Note 5)	1,042	1,191
Current liabilities of discontinued operations (Note 21)	0	2,200
Total current liabilities	2,975	5,037
Long-term liabilities:
Long-term debt (Note 8)	5,331	7,467
Pension benefit obligations	212	212
Long-term operating lease liabilities	241	270
Other long-term liabilities (Note 5)	484	479
Long-term liabilities of discontinued operations (Note 21)	0	449
Total long-term liabilities	6,268	8,877
Total liabilities	9,243	13,914
Commitments and contingencies (Note 10)
Redeemable noncontrolling interest (Note 2)	0	102
Shareholders' equity:
Preferred shares, $0.01 par value per share, 50,000,000 shares authorized, none issued and outstanding	0	0
Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 208,365,500 and 212,746,899 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	2	2
Additional paid-in capital	3,613	3,619
Retained earnings	5,578	6,227
Accumulated other comprehensive loss (Note 13)	(440)	(641)
Total Aptiv shareholders' equity	8,753	9,207
Noncontrolling interest	0	190
Total shareholders' equity	8,753	9,397
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 17,996	$ 23,413